Peptidoglycan (PG) is a mesh-like macromolecule that surrounds the cytoplasmic membrane of nearly all bacteria, protecting them from environmental stress and dictating cell morphology throughout their life.^[@R1]--[@R3]^ PG biosynthesis requires transpeptidation reactions for cross-linking PG glycan backbones via short peptide chains.^[@R4]^ There are three types of transpeptidation reactions involved in PG biosynthesis: 1) D,D-transpeptidation constructs PG 3--4 crosslinks which are normally essential for bacterial viability. β-lactam antibiotics, such as penicillin, induce cytotoxicity via inhibition of D,D-transpeptidation catalyzed by penicillin-binding proteins (PBPs);^[@R5]--[@R8]^ 2) L,D-transpeptidation produces PG 3--3 crosslinks and is conducted by L,D-transpeptidases (Ldts)^[@R9]^. Although Ldts are normally not essential in most species, their activities help cells bypass β-lactam toxicity in some bacteria;^[@R10],[@R11]^ and 3) sortase-catalyzed transpeptidation anchors surface proteins to the PG structure. Inhibition of sortase activity results in defective cell growth and infections in some species.^[@R12],[@R13]^

Monitoring transpeptidation activity *in vivo* and *in vitro* remains challenging even though it has been studied for almost a century.^[@R14]^ Previously, we reported the use of fluorescent D-amino acids (FDAAs) for PG labeling in various bacterial species.^[@R15]--[@R19]^ FDAAs incorporate into PG peptide chains through D,D-transpeptidation and/or L,D-transpeptidation activity by enzyme-substrate mimicry.^[@R4],[@R15]^ Thus, FDAA labeling reflects transpeptidation reactions and allows direct observation of PG cross-linking activities. Nevertheless, continuous tracking of transpeptidase activities remains difficult. Sequential labeling using different colored FDAAs has been applied to study PG formation in real time, but the requirement of vigorous cell washing and lengthy harvest steps greatly reduces the temporal resolution of the experiments.^[@R16],[@R17],[@R19]^ This requirement not only creates a time gap between the labeling pulses, but could also disturb the physiology of the cell. This, in turn, makes the interpretation of experiments involving highly dynamic process, e.g. the coordination of different PG synthases, difficult. Therefore, probes capable of continuous monitoring of PG transpeptidation activity with high temporal resolution and minimal cell disruption are in a great demand. These probes would allow in-depth elucidation of PG biosynthesis, providing new insights into bacterial propagation and its inhibition.

Fluorescent molecular rotors (FMRs) are a class of fluorophores whose emission intensity is sensitive to the ability of the environment to restrict bond rotation (or known as spatial hindrance).^[@R20]^ In a low-hindrance environment, photo-excited FMRs adopt a twisted intramolecular charge transfer state (TICT) and release energy through red-shifted emission or non-radiative relaxation. Thus, no fluorescence signal is detected ("off state"). Under high spatial hindrance, conversion to the TICT state is inhibited, resulting in energy release through fluorescence emission ("on state"). The "on-off" property of FMRs has been classically used for measuring viscosity, but it has recently been applied to detect protein and DNA interactions as well.^[@R21]--[@R26]^ Inspired by this property, we hypothesized that the incorporation of FMRs into PG, a congested environment, would be sufficient to provide a fluorogenic response.^[@R24],[@R27],[@R28]^

In this study, we report the first design and synthesis of three molecular rotor-fluorogenic DAAs (RfDAAs) and confirm their D,D- and L,D- transpeptidase-mediated incorporation into the PG layer of Gram-positive and Gram-negative bacteria. We show that end-point imaging of PG labeling can be carried out using RfDAAs without washing steps. Their "on-off" property enables, for the first time, time-lapse monitoring of PG growth in live cells. In addition, we demonstrate the use of the probes for *in vitro*, real-time activity assays of three types of transpeptidases. We evaluate the potential of RfDAA applications for a high-throughput transpeptidation assay that will significantly advance the studies of PG synthase mechanisms and kinetics analysis, as well as new antibiotic development.

Results {#S1}
=======

Synthesis of Rotor-fluorogenic DAAs (RfDAAs) {#S2}
--------------------------------------------

Fluorescent molecular rotors have been developed on several types of scaffolds, most notably benzonitrile and julolidine.^[@R20],[@R29]^ To enable cell labeling, we aimed to design RfDAAs having high water-solubility, stability, and biocompatibility. We started with a tetrahydroquinoline core whose derivatives showed molecular rotor properties and have been applied in studies under physiological conditions.^[@R30]^ Synthesis was initiated with an N-alkylation of tetrahydroquinoline with methyl acrylate to create a linker for subsequent D-amino acid coupling ([Fig. 1](#F1){ref-type="fig"}).^[@R31]^ The resulting ester (**1**) was formylated through a Vilsmeier-Haack reaction, followed by ester hydrolysis to provide aldehyde **2**. Condensation with *t*-butyl cyanoacetate gave the molecular rotor **3**, which was coupled with D-lysine and deprotected to provide **Rf420DL** (**R**otor-**f**luorogenic **420 D-l**ysine).

**Rf420DL** possesses a maximum excitation wavelength (Max. λ~Ex~) of 420 nm and a maximum emission wavelength (Max. λ~Em~) of 490 nm ([Table 1](#T1){ref-type="table"}, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Due to photo-toxicity concerns caused by low wavelength excitation, we inserted a thiophene group to the molecule to provide red-shifted λ~Ex~/λ~Em~ as previously reported by Shao *et al.*^[@R32]^ Synthesis began with iodination to provide intermediate **4**. After ester hydrolysis, Suzuki-Miyaura coupling of thiophenyl aldehyde trifluoroborate was applied to generate intermediate **5**.^[@R33],[@R34]^ The synthesis was completed via condensation with *t*-butyl cyanoacetate (**6**), coupling with Boc-D-lysine, and final deprotection to give **Rf470DL**. **Rf470DL** has a max. λ~Ex~ of 470 nm (a red-shift of 50 nm compared to **Rf420DL**) and a max. λ~Em~ of 640 nm. Finally, to study the effect of molecular geometry on PG labeling, we prepared a structural isomer of **Rf470DL**, called **Rf490DL**, where D-lysine is coupled to the vinyl carboxylate group instead of the N-alkyl linker. A red-shift of 20 nm was found in the Max. λ~Ex~ compared to **Rf470DL**.

RfDAAs enable end-point PG imaging without washing {#S3}
--------------------------------------------------

To test their utility for PG labeling, we incubated RfDAAs with two Gram-positive species, *S. venezuelae* (15 min, 1/3 doubling time) and *B. subtilis* (1 hour, 3 doubling times), and directly imaged the cells without washing and fixation ([Fig. 2a](#F2){ref-type="fig"}, [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). With the short-pulse incubation, newly synthesized PG in *S. venezuelae* was clearly detected at the poles; while the long-pulse incubation in *B. subtilis* resulted in full cell wall labeling. These labeling patterns are consistent with the control samples using standard FDAA, HADA.^[@R15]--[@R17]^ However, washing steps were required to remove excess dye for imaging HADA labeling. Otherwise, strong background fluorescence saturated the fluorescence signal and prevented PG imaging ([Fig. 2b](#F2){ref-type="fig"}). In comparison, PG labeling using RfDAAs could be observed without washing steps. The specific labeling of PG with RfDAAs was confirmed by visualizing **Rf470DL** signal in isolated sacculi from *B. subtilis* ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Control experiments using L-enantiomers of RfDAAs showed no significant signal under the same labeling and imaging condition, suggesting that RfDAA labeling is mediated by PG transpeptidase activity ([Fig. 2b](#F2){ref-type="fig"}, [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}).

The outer-membrane (OM) in Gram-negative species is an effective barrier that prevents the entry of molecules from the environment.^[@R35]^ To investigate the utility of RfDAAs in Gram-negative bacteria, we determined their OM permeability by performing a long-pulse labeling in wild-type *Escherichia coli* (*E. coli* WT) and a mutant with increased membrane permeability (*E. coli imp*).^[@R36]^ In WT cells, no significant signal above the background was detected with all the RfDAAs ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). In contrast, up to a 7-fold signal increase was observed in *E. coli imp* with **Rf470DL** and **Rf490DL** ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). This suggested that the OM presents a substantial barrier for the labeling. Thus, permeabilizing the OM might be required to label Gram-negatives with RfDAAs. **Rf420DL** showed faint fluorescence signal even in *E. coli imp*. We wondered whether **Rf420DL** is toxic to the cells so we measured the growth curves of *E. coli imp* and *B. subtilis* in the presence of RfDAAs ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). It appears that all the RfDAAs are highly biocompatible in these species at 1 mM concentration. No significant growth delay was found in the RfDAA samples compared to the DMSO controls. Thus, the low labeling signal of **Rf420DL** is not due to toxicity but probably its photochemical properties ([Supplementary discussion 1](#SD1){ref-type="supplementary-material"}).

We hypothesized that the PG layer constrains the conformation of the RfDAAs, leading to fluorescence release. In further support of this, we determined the viscosity sensitivity (χ) of RfDAAs by measuring their fluorescence intensity as a function of solvent viscosity using a glycerol gradient ([Table 1](#T1){ref-type="table"}). All the probes have a \~20 fold intensity increase in 80% glycerol-PBS compared to pure PBS ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). The calculated viscosity sensitivity of RfDAAs is about 0.65, a typical value for fluorescent molecular rotors.^[@R37],[@R38]^ HADA intensity remained the same in this test with a χ value of 0.025, showing that HADA does not have molecular rotor properties. We were then interested in the viscosity sensitivity of incorporated RfDAAs in PG structures. If the dyes inside the PG layer are sterically restricted into the "on" state, we would expect a decreased viscosity sensitivity. We prepared *B. subtilis* cells labeled with **Rf470DL** for 1 hour, followed by fixing the cells with ethanol and washing with PBS twice. The pellets were then resuspended in glycerol-PBS solution for fluorescence measurement. We found that incorporated **Rf470DL** showed significantly decreased viscosity sensitivity (χ=0.27), indicating that the molecular rotors had already achieved a highly constrained state likely due to the PG surroundings ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Thus, incorporation into the cell wall is sufficient to activate the fluorescence state of RfDAAs.

Real-time imaging of PG synthesis with Rf470DL {#S4}
----------------------------------------------

We chose **Rf470DL** for time-lapse experiments because it possesses the highest quantum yield and absorptivity ([Table 1](#T1){ref-type="table"}). Cells were spotted on an LB-agarose pad containing **Rf470DL** and imaged continuously using epifluorescence microscopy ([Fig. 3a](#F3){ref-type="fig"}). In *S. venezuelae*, a polarly growing bacterium, **Rf470DL** signal was first seen at growing poles, newly developed branches, and division septa ([Fig. 3b](#F3){ref-type="fig"}, [Supplementary Movie 1](#SD2){ref-type="supplementary-material"}). The labeled area extended over time along with the elongation of the poles and new cell branches. The formation of new septa could be observed clearly during the time-lapse imaging. On the other hand, in *B. subtilis,* **Rf470DL** signal increased gradually throughout the cell body with the dimmest intensity at the poles ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}, [Supplementary Movie 2](#SD3){ref-type="supplementary-material"}). This is consistent with the dispersed growth mode in this species as reported previously.^[@R39]^ The formation of division septa could also be seen in real time. Thus, we conclude that RfDAAs enable real-time monitoring of PG synthesis in live cells. Since washing steps are no longer required, RfDAA labeling provides improved temporal resolution compared to sequential FDAA labeling. Interestingly, we also found that non-growing cells showed extremely strong fluorescence signal throughout the whole cell body ([Supplementary Movie 3](#SD4){ref-type="supplementary-material"}). This is probably due to membrane permeabilization in dying cells, which allows the entrance of RfDAAs into the cytoplasm, a relatively viscous environment that may turn on the probes. Thus, permeabilized and dying cells can be easily distinguished from live cells during time-lapse experiments using RfDAAs.

Real-time assays of transpeptidase activity using Rf470DL {#S5}
---------------------------------------------------------

*In vitro* assays to study D,D-transpeptidation activity have been developed previously and have greatly advanced our understanding of PBP kinetics as well as PG synthesis mechanisms.^[@R4],[@R14],[@R40]--[@R43]^ However, due to the presence of strong background noise from the leftover probes, signal output in the existing transpeptidase assays can only be obtained after product purification processes. This complicates the experiments and increases the amount of human works. Given that RfDAAs are fluorogenic probes that fluoresce upon PG incorporation, we developed a continuous, spectrophotometric assay to monitor transpeptidation reactions without the need of product purification. The component of the assay includes RfDAA probes as the fluorescence reporter, synthetic diacetyl-L-lysine-D-alanine-D-alanine as the substrate (acyl donor) and *Staphylococcus aureus* PBP4 enzyme. *S. aureus* PBP4 is a known D,D-transpeptidase responsible for PG cross-linking in staphylococci, as well as a β-lactamase that degrades penicillin-like antibiotics.^[@R44],[@R45]^ Knocking out PBP4 results in significantly decreased resistance to β-lactams in methicillin-resistant *S. aureus* (MRSA), suggesting that it is a valuable target for new antibiotic development.^[@R46]^

*S. aureus* PBP4 was added to a mixture of **Rf470DL** and the synthetic substrate in a 96-well plate. The fluorescence intensity of the samples was then measured over time using a plate reader ([Fig. 4a](#F4){ref-type="fig"}). An increase in intensity was observed ([Fig. 4b](#F4){ref-type="fig"}) and the formation of cross-linked product was confirmed by reverse-phase HPLC and high-resolution mass spectrometry ([Fig. 4c, d](#F4){ref-type="fig"}). Control experiments using the L-enantiomer of **Rf470DL** showed no signal increase in the assay ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}), which is in agreement with the stereocenter selectivity of PBPs. To confirm that the reaction was carried out by enzyme activity, a known effective inhibitor of *S. aureus* PBP4, cefoxitin, was added to the reaction. A total inhibition of the D,D-transpeptidation activity was observed.^[@R46]^ In contrast, when chloramphenicol, a ribosome peptidyl transferase inhibitor, was added, no inhibition effect was found. These results indicated that the signal increase in the assay results from *S. aureus* PBP4 activity, and that RfDAAs could be employed for real-time monitoring of D,D-transpeptidation reaction *in vitro*. In addition, a dose-dependent experiment using cefoxitin indicated a total inhibition of *S. aureus* PBP4 activity at 5 μg/ml (estimated IC~50~= 1 μg/ml), consistent with the reported MIC value in this species ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}).^[@R47]^

We further evaluated the utility of this assay for high-throughput screening for antibiotics. We tested various antibiotics and measured the initial rate of fluorescence increase ([Fig. 4e](#F4){ref-type="fig"}). As expected, antibiotics targeting the protein synthesis machinery showed no significant effect to *S. aureus* PBP4 activity; whereas β-lactam derivatives had inhibitory activities: Cefoxitin and Carbenicillin inhibited the enzyme reaction almost completely; Penicillin G and Ampicillin showed partial inhibition; and Piperacillin, a selective inhibitor of *E. coli* PBP3 ^[@R48]^, did not have a significant effect on *S. aureus* PBP4 activity. This result is consistent with the published inhibitory concentration of these β-lactams against *S. aureus*.^[@R49]^ To further confirm the observed inhibitory effects, we performed a Nitrocefin test, which determines PBP's β-lactamase activity, in the presence of these antibiotics.^[@R50],[@R51]^ We found that, in the presence of Cefoxitin or Carbenicillin, Nitrocefin hydrolysis was strongly inhibited (\> 50 %, [Fig. 4f](#F4){ref-type="fig"}). However, Piperacillin and Ampicillin treatments did not inhibit PBP4s β-lactamase activity effectively, indicating a low inhibitory effect toward PBP4. Together, these results suggest that RfDAAs can be used to quantitatively measure the effect of β-lactams on the transpeptidation activity of PBPs. We also note that this assay can be conducted in an end-point manner, providing an efficient way to test a large number of samples since only a single measurement is required per sample ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}).

In addition to PBPs, we tested the RfDAA assay in other classes of transpeptidases: L,D-transpeptidases (Ldts) and Sortases. It is known that LdtA, encoded by *V. cholerae vc1268*, is responsible for 3'−3' cross-linkage formation^[@R52]^. Incubation of LdtA with **Rf470DL** and a synthetic tetrapeptide (diacyl-L-Ala-D-Glu-L-Lys-D-Ala) leads to a time-lapse increase of fluorescence signal, similar to our observations in the *S. aureus* PBP4 experiments ([Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}). On the other hand, *S. aureus* Sortase A (SrtA) is responsible for anchoring surface proteins to PG through a sequence-specific transpeptidation reaction^[@R13]^. It recognizes a conserved protein LPXTG motif and cross-links it with PG pentaglycine in *S. aureus*. We incubated Sortase A with synthetic pentapeptide motif (LPETG) in the RfDAA assay and observed an increase of **Rf470DL** signal over time ([Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}). Control experiments in the absence of the substrate led to no signal change. These results suggest that our *in vitro* RfDAA assay is highly applicable in transpeptidase activity measurement for studying PG-to-PG and PG-to-protein cross-linking reactions.

Discussions {#S6}
===========

Tracking PG biosynthesis during the life cycle of a bacterial cell has been a long-term challenge in the field of PG studies. Sequential PG labeling using FDAAs has a limited temporal resolution (\> 15 s) due to the need of removing background fluorescence caused by the unincorporated dye.^[@R19]^ Fluorogenic probes, such as RfDAAs, can match the superior temporal resolutions (\< 1 s) of cutting-edge protein-tracking methods toward understanding the spatiotemporal coordination between PG synthases and PG synthesis. Since washing steps are no longer required and the cells can be imaged directly after treated to RfDAAs, the temporal resolution of RfDAA labeling is simply defined by the microscope capability and can easily achieve sub-second scale. The removal of washing steps also minimizes the perturbation to bacterial cells. These improvements would allow close tracking of PG formation that proceeds fast (e.g. PG formation in short doubling-time species) as well as simultaneous monitoring of enzyme localization versus PG growth activities (e.g. the localization of active PBPs and newly formed PG).

PG transpeptidation reactions are valuable antibiotic targets because there is no PG equivalent in eukaryotic systems, which reduces toxicity effects to human patients. *In vitro* transpeptidase assays are powerful tools for identifying new PG-specific inhibitors. However, efficient drug development cannot be achieved until low-cost, high-throughput screening methods become available. Under the mounting stress of bacterial resistance, developing such an efficient screening method becomes urgent. RfDAAs allow specific PG labeling through transpeptidase activities. Endowed by their fluorogenic properties, RfDAA assays bypass the need of staining and/or purification processes. This greatly reduces the cost and time from the current HPCL-based approaches, increasing the efficiency toward new drug screens. In addition, we show that RfDAAs can report the activities of other classes of transpeptidases, L,D-transpeptidases (LdtA, *V. cholerae*) and sortases (SrtA. *S. aureus*), that are both proposed to be new antibiotic targets with few inhibitors available.^[@R11],[@R13],[@R53],[@R54]^ The broad applicability of the assay also suggests that RfDAAs could be applicable to other transpeptidation reactions, such as eukaryotic transglutaminases.^[@R55]^ Therefore, *in vitro* RfDAA assays could facilitate high-throughput screens toward the discovery of a variety of drug candidates.

Finally, as a prospect of future application, the turn-on behavior of RfDAAs upon incorporation into the PG stem peptide sets this class of amino acids as powerful new protein tags. The wash-free labeling of proteins with these small fluorogenic amino acids at the L-chirality using genetic code expansion could improve upon current fluorescent protein labeling technologies for most applications.^[@R56]^ These probes would perturb the tagged protein minimally and would be instantly visible upon protein incorporation as they do not require maturation or oxygen to fluoresce.

To conclude, in this study, we demonstrate the use of RfDAAs, the first fluorogenic amino acids that fluoresce only upon incorporation into PG. As D-amino acid derivatives, RfDAAs label PG through PBP transpeptidation activity, therefore allowing real-time monitoring of PG synthesis *in vivo* as well as continuous transpeptidation assays *in vitro*. We show the potential of RfDAAs for studying mechanisms of PG synthesis both at the sub-cellular and enzyme kinetics level, and for high-throughput screening of novel antibacterial drugs.

Methods {#S7}
=======

For more discussions and experimental details, please refer to Electronic [Supporting Information (ESI)](#SD1){ref-type="supplementary-material"}.

Supplementary Material {#SM1}
======================

We thank Kerwyn Casey Huang for providing strain *E. coli imp4213*, Suzanne Walker for providing *S. aureus* PBP4 plasmid, David Kysela for help on image processing and analysis, and Jonathan Rittichier for providing the enzyme substrates used in the *in vitro* assays and his kind advice on RfDAA synthesis. This study is supported by NIH grants 5R01GM113172 to MSV and YVB; and R35GM122556 to YVB.

Competing Interests

The authors declare no completing interests.

Data Availability

All data are available upon reasonable request to the corresponding authors.

![Synthetic routes for preparation of the RfDAAs.\
Each synthetic route utilized an alkylated tetrahydroquinoline core structure (**1**) that incorporated an ester group to provide a functional handle for subsequent D-amino acid coupling. After Vilsmeier-Haack formylation, condensation with *t*-butyl cyanoacetate provided the fluorogenic fluorophore, Rf420 (**3**), which was coupled with D-Lys to generate **Rf420DL**. A similar strategy was used to prepare **Rf470DL**. A thiophene spacer, installed via iodination of the aryl ring and a subsequent Suzuki-Miyaura coupling reaction, was added to the tetrahydroquinoline core in order to further extend conjugation (e.g., **6**). **Rf490DL**, a constitutional isomer of **Rf470DL**, was prepared by coupling D-Lys to the deprotected α-cyanoacrylic acid subunit (**7**).](nihms-1518496-f0002){#F1}

![Unlike FDAAs, RfDAAs allow wash-free imaging of bacterial cell walls.\
a) Scheme of labeling process. Bacterial cells were incubated with either RfDAAs or FDAA for PG labeling. The labeled cells were then collected and imaged with or without washing steps. b) Cell images shown in phase contrast (upper row) and fluorescence (bottom row) channels. Top panel: short-pulse labeling in *S. venezuelae* (1/3 doubling time); bottom panel: long-pulse labeling in *B. subtilis* (3 doubling times). PG labeling using RfDAAs (red) can be imaged without washing steps; whereas FDAA labeling (cyan) before washing steps results in saturated background fluorescence due to excess FDAAs in the field of view. Identical labeling, imaging and processing protocols were used for the comparison between D- and L- enantiomer labeling, as well as for unwashed and washed HADA labeling. Scale bar: 5 μm.](nihms-1518496-f0003){#F2}

![RfDAAs allow real-time imaging of PG synthesis in *S. venezuelae*.\
a) Scheme of labeling process. Pre-warmed liquid mixture of LB-agarose and **Rf470DL** was added to a cavity slide. After the mixture was solidified, cells were loaded on top of the agarose pad and then covered with a coverslip. Real-time PG labeling was then observed using time-lapse fluorescence microscopy while the cells were growing in the slides. b) Montage image of **Rf470DL** time-lapse labeling in *S. venezuelae.* Newly synthesized PG structures are revealed by the appearance of new **Rf470DL** signal (red). The extension of peripheral PG, the formation of septal PG and the formation of new cell branches are revealed by the **Rf470DL** signal over time. Yellow arrowheads: newly formed septal PG; white arrowhead: newly formed cell branches. See [Supplementary Movie 1](#SD2){ref-type="supplementary-material"}. Scale bar: 5 μm.](nihms-1518496-f0004){#F3}

![RfDAAs facilitate real-time *in vitro* transpeptidation assays.\
a) Scheme of assay procedure. **Rf470DL** and the synthetic substrate were mixed in a 96-well plate. The fluorescence intensity of **Rf470DL** was then measured over time upon the addition of recombinant *S. aureus* PBP4. b) Real-time monitoring of **Rf470DL** intensity. An intensity increase was observed in the assay; while adding PBP inhibitors blocked the reaction. c) HPLC analysis of the assay products. A shifted retention time was observed when the **Rf470DL**-substrate mixture was treated with PBP4. d) High-resolution MS analysis of the products from the assay confirmed the formation of the cross-linked product. e) Screening of antibiotic effect on *S aureus* PBP4 activity. A 1:10 ratio of antibiotics to the substrate was used in the experiments. Kanamycin and Chloramphenicol (ribosome inhibitors) did not inhibit the **Rf470DL** incorporation. Piperacillin, Ampicillin, Penicillin G, Carbenicillin and Cefoxitin (β-lactam antibiotics) showed different level of inhibition. f) β-lactamase activity of *S. aureus* PBP4. A competition assay using Nitrocefin was performed to study PBP4 β-lactamase activity toward the β-lactam antibiotics used in the assay experiments. In this panel, low activity stands for a strong inhibition effect of the antibiotics toward PBP4, and vice versa. Values are normalized to the "no antibiotic" sample. Error bars: Mean value and standard deviation.](nihms-1518496-f0005){#F4}

###### 

Photochemical and physical properties of RfDAAs.

                                                                                       Rf420DL        Rf470DL       Rf490DL       HADA
  ------------------------------------------------------------------------------------ -------------- ------------- ------------- --------------
  MW (unsalted)                                                                        428.5          510.6         510.6         292.1
  Max. λ~Ex~^[a](#TFN1){ref-type="table-fn"}^                                          420            470           490           400
  Max. λ~Em~^[a](#TFN1){ref-type="table-fn"}^                                          490            640           660           450
  Viscosity sensitivity (X)                                                            0.683±0.013    0.642±0.022   0.670±0.003   0.025±0.003
  Quantum Yield (ɸ)^[a](#TFN1){ref-type="table-fn"},[b](#TFN2){ref-type="table-fn"}^   0.012          0.042         0.035         NA
  Absorptivity (ε)^[c](#TFN3){ref-type="table-fn"}^                                    19761          33106         25409         109538
  Water-solubility (LogD~7.4~)^[d](#TFN4){ref-type="table-fn"}^                        −1.497±0.045   −1.150±0.09   −1.10±0.07    −1.059±0.076
  Thermo-stability ^[c](#TFN3){ref-type="table-fn"},[e](#TFN5){ref-type="table-fn"}^   99.8±1.2%      99.4±1.4%     96.9±9.8%     80.0±1.1%

Data were measured in PBS (pH 7.4) containing 50% glycerol.

Fluorescein was used as a standard for quantum yield measurements.

Data were measured in PBS (pH 7.4).

Data were measured using a PBS (pH 7.4) and 1-octanol extraction. A smaller value represents greater water solubility.

Value represents signal retention of absorbance after a 24-hours incubation at 60 °C compared to the corresponding initial value.
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